BLTE
Belite Bio, Inc
NASDAQ · Healthcare · Biotechnology · US
$193.61
+13.16%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 106.85x
- P/E 2028E
- 29.59x
- P/S forward
- 35.10x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 10.04x
- Price / sales
- —
- Price / cash flow
- —
Enterprise value
- Enterprise value
- $7.8B
- EV / sales
- —
- EV / EBITDA
- -68.27x
- EV / EBIT
- -65.70x
- Market cap
- $7.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026